Promising New Zealand compound selected as drug candidate for tuberculosis
17 September 2012
A New Zealand-designed compound that shows promise against treatment-resistance tuberculosis (TB) has been selected as a drug candidate by international non-profit drug developer the Global Alliance for TB Drug Development (TB Alliance).
Investigators part of consortium awarded international grant
8 June 2012
The Wellcome Trust (UK) has approved a three-year, $NZ 8.8 million international grant to support a consortium of research groups in New Zealand and Australia to continue the development of a new class of immune-suppressive drugs to protect transplanted bone marrow stem cell...
Investigator awarded major Health Research Council grant
7 June 2012
Maurice Wilkins Centre principal investigator Professor John Fraser and his research team at The University of Auckland were awarded significant funds in the annual Health Research Council of New Zealand grant round, for their research tackling infectious disease.
Symposium on tuberculosis drug discovery and immunology
17 May 2012
This month the Maurice Wilkins Centre hosted a special two-day symposium on tuberculosis drug discovery and immunology highlighting links between New Zealand and Colorado State University. The event, which was open to all interested members of the scientific community, was h...